• PDF / 170,114 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 60 Downloads / 145 Views

DOWNLOAD

REPORT

1173-5503/20/0868-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 12 Dec 2020 No. 868

1

Recommend Documents

Cost-Effective

168 109 57MB

Highly Cost-Effective Intervention

195 83 57MB

Atomoxetine cost-effective in ADHD

158 88 139KB

Atorvastatin cost effective in T2DM

163 57 182KB

Avoiding breaks with bisphosphonates is cost effective

196 9 124KB

Synflorix cost effective versus PCV13 in Taiwan

208 39 182KB

Cost effective C. difficile prevention strategies

177 76 194KB

Bevacizumab + capecitabine not cost effective in mCRC

162 48 111KB

Semaglutide cost effective versus dulaglutide in Japan

170 20 182KB

Heplisav-B cost effective versus Engerix-B

168 82 166KB

Once-monthly ibandronic acid cost effective

141 94 122KB

Trastuzumab cost effective in early breast cancer

115 43 122KB